Home
>
US Stocks
>
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc
ENTA

Enanta Pharmaceuticals Inc (ENTA)

$59.93.36%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$61.55
Today Low/High$58.33 / $62.92
52 Week Low/High$40.37 / $102
P/E ratio-7.66
Market Cap$1.41B

Company Details

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. Enanta's research and development efforts have produced clinical candidates for the following disease targets: respiratory syncytial virus (RSV), non-alcoholic steatohepatitis (NASH) and hepatitis B virus (HBV). Enanta is also conducting research in human metapneumovirus (hMPV) and emerging coronaviruses, including SARS-CoV-2.
OrganisationEnanta Pharmaceuticals Inc
HeadquatersWatertown, Massachusetts, US
Employees141
IndustryHealth Technology
CEOJay Luly

Discover more

Frequently Asked Questions

What is Enanta Pharmaceuticals Inc (ENTA) share price today?

Can Indians buy Enanta Pharmaceuticals Inc (ENTA) shares?

How can I buy Enanta Pharmaceuticals Inc (ENTA) shares from India?

Can Fractional shares of Enanta Pharmaceuticals Inc (ENTA) be purchased?

What are the documents required to start investing in Enanta Pharmaceuticals Inc (ENTA) stocks?